Home > Healthcare > Pharmaceuticals > Drug Delivery > Nanotechnology-based Drug Delivery Market

Nanotechnology-based Drug Delivery Market Share

Report ID: GMI6208
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Nanotechnology-based Drug Delivery Market Share

Major market players operating in the nanotechnology-based drug delivery market include:

AbbVie Inc.
BlueWillow Biologics Inc.
Camurus AB
Celgene, Inc.
Cristal Therapeutics
EyePoint Pharmaceuticals
Johnson

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for nanotechnology-based drug delivery accounted for USD 95.2 billion in 2022 and is estimated to grow at a CAGR of 12.6% through 2032, owing to the growing preference for precision medicines.

Nanoparticles technology segment will grow at 12.4% CAGR through 2032. Continuous advancements in nanomaterials have led to the development of a diverse range of nanoparticle platforms, thereby offering flexibility and versatility in drug delivery applications.

North America market for nanotechnology-based drug delivery accounted for 46.6% revenue share in 2022 and will grow at considerable rate in the coming years, backed by the increasing prevalence of chronic diseases, a high disposable income, and robust healthcare infrastructure.

AbbVie Inc., BlueWillow Biologics Inc., Camurus AB, Celgene, Inc., Cristal Therapeutics, EyePoint Pharmaceuticals, and Johnson and Johnson, among others.